Lana Medical Company CJSC

Lana Medical Company CJSC has a debt-to-equity ratio of 0.45, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's current ratio of 1.58 suggests it has sufficient short-term assets to cover its short-term liabilities, though its operating cash flow is negative at -5.64 million SAR, which may signal potential liquidity challenges in the near term. In terms of profitability, the company's return on equity (ROE) is 4.14%, and its return on assets (ROA) is 2.04%. These figures are below the industry median for ROE and ROA in the Environmental Services & Equipment sector, suggesting that the company is underperforming its peers in terms of generating returns from its equity and asset base. The company's revenue is concentrated in Saudi Arabia, as it is a domestic-based firm with no disclosed international operations. This geographic concentration may expose the company to local economic and regulatory risks, particularly in the healthcare and environmental services sectors. Looking ahead, the company's revenue is expected to grow, though the exact magnitude of the growth is not specified. The company's free cash flow of 3.70 million SAR indicates that it is generating positive cash from operations after capital expenditures, which could support future growth initiatives or debt reduction. The company's risk profile is characterized by medium liquidity risk and low dilution risk. However, the negative net cash position after subtracting total debt raises concerns about its ability to meet short-term obligations without external financing. The company has not disclosed any recent equity issuances or dilution events, and its diluted shares outstanding remain unchanged at 54 million. Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company continues to focus on its core business of medical equipment distribution and waste management, with no significant new product launches or market expansions disclosed in the latest financial reports.